Update on the Therapeutic Drug Monitoring in IBD: Is it Time We Use it in Situations other Than Loss of Response

2014 Summit Faculty interview with Louis Kuritzky, MD, about some of the benefits and risks of statin treatment, including the risk of developing diabetes. 

“We have a long way to go to meet dietary recommendations,” said study author Shilpa Bhupathiraju, PhD, from Harvard Medical School.

Uni Wong, MD, from the University of Maryland School of Medicine, discusses the presentation she gave at the Advances in Inflammatory Bowel Disease virtual regional meeting on September 12 on infectious...